Double staining showed that approximately 70% of the CD40-positive macrophages in MS lesions also expressed MR, indicating that the majority of infiltrating macrophages and activated microglial cells display an intermediate activation status [9], [12]. The gene discussed is NR3C2; the disease is myeloid sarcoma.